by McDermott + Bull | Nov 24, 2022 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article
Heading into 2022, many expected the rapid continuation of strong initial public offerings (IPOs) and merger + acquisition (M+A) activity. Wow, that was off. The underestimated implications of supply chain issues, geopolitical concerns, and Federal Trade Commission...
by McDermott + Bull | May 27, 2022 | Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article
THE STATE OF WOMEN IN THE HEALTHCARE + LIFE SCIENCES WORKFORCE McKinsey & Company is one of the top companies when it comes to collecting data, identifying trends, and suggesting actions and strategies that address potential issues. The article, “Women in...
by McDermott + Bull | Feb 3, 2022 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article
LIFE SCIENCES + HEALTHCARE OUTLOOK IN 2022 When the J.P. Morgan Healthcare Conference took place last January, I skipped it, optimistically thinking that things would be different and safer the following year. Shortly before this year’s conference, it was announced...
